Key result
Review examines clinical implications of thiazolidinediones in patients with diabetes and heart failure.
Answers are grounded in this paper and cite their sources.
Samy I McFarlane1† & Fadi A El-Atat2 †Author for correspondence 1†SUNY-Downstate and Kings County Hospital Centers, Division of Endocrinology, Diabetes and Hypertension, 450 Clarkson Avenue, Box 50, Brooklyn, NY, 11203, USA Tel: +1 718 270 3711 Fax: +1 718 270 6358 2SUNY-Downstate and Kings County Hospital Centers, Division of Cardiovascular Medicine, 450 Clarkson Avenue, Box 50 Brooklyn, NY, 11203, USA
No takes yet. Share an insight, caveat, or question.
McFarlane et al. (2005) conducted a review in Heart failure and diabetes. Thiazolidinediones was evaluated. The abstract provides no clinical data, only author affiliations for a paper discussing heart failure, diabetes, and thiazolidinediones.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: